A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).

Item

http://www.wikidata.org/entity/Q37041204

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A randomized phase III trial c ...... l cancer (JFMC35-C1: ACTS-RC).

@en

A randomized phase III trial c ...... for stage II/III rectal cancer

@nl

type

Item

label

A randomized phase III trial c ...... l cancer (JFMC35-C1: ACTS-RC).

@en

A randomized phase III trial c ...... for stage II/III rectal cancer

@nl

prefLabel

A randomized phase III trial c ...... l cancer (JFMC35-C1: ACTS-RC).

@en

A randomized phase III trial c ...... for stage II/III rectal cancer

@nl

P1476

A randomized phase III trial c ...... l cancer (JFMC35-C1: ACTS-RC).

@en

P2093

A Murata

http://www.w3.org/2001/XMLSchema#string

C Hamada

http://www.w3.org/2001/XMLSchema#string

C Matsuda

http://www.w3.org/2001/XMLSchema#string

E Oki

http://www.w3.org/2001/XMLSchema#string

H Baba

http://www.w3.org/2001/XMLSchema#string

H Matsuda

http://www.w3.org/2001/XMLSchema#string

K Ikejiri

http://www.w3.org/2001/XMLSchema#string

K Maeda

http://www.w3.org/2001/XMLSchema#string

K Sasaki

http://www.w3.org/2001/XMLSchema#string

K Yoshida

http://www.w3.org/2001/XMLSchema#string

P2860

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.

S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial).

Chemotherapy with preoperative radiotherapy in rectal cancer.

Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.

Colorectal cancer statistics, 2014.

S-1 for the treatment of gastrointestinal cancer.

Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control.

Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.

Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.

P304

1266-1272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDW162

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27056996

http://www.w3.org/2001/XMLSchema#string

P921

phase III clinical trial

chemotherapy

P932

4922318

http://www.w3.org/2001/XMLSchema#string